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Abstract
The globally distributed ectoparasite Varroa destructor is a vector for viral pathogens of the Western honeybee (Apis
mellifera), in particular the Iflavirus Deformed Wing Virus (DWV). In the absence of Varroa low levels DWV occur, generally
causing asymptomatic infections. Conversely, Varroa-infested colonies show markedly elevated virus levels, increased
overwintering colony losses, with impairment of pupal development and symptomatic workers. To determine whether
changes in the virus population were due Varroa amplifying and introducing virulent virus strains and/or suppressing the
host immune responses, we exposed Varroa-naı¨ve larvae to oral and Varroa-transmitted DWV. We monitored virus levels
and diversity in developing pupae and associated Varroa, the resulting RNAi response and transcriptome changes in the
host. Exposed pupae were stratified by Varroa association (presence/absence) and virus levels (low/high) into three groups.
Varroa-free pupae all exhibited low levels of a highly diverse DWV population, with those exposed per os (group NV)
exhibiting changes in the population composition. Varroa-associated pupae exhibited either low levels of a diverse DWV
population (group VL) or high levels of a near-clonal virulent variant of DWV (group VH). These groups and unexposed
controls (C) could be also discriminated by principal component analysis of the transcriptome changes observed, which
included several genes involved in development and the immune response. All Varroa tested contained a diverse replicating
DWV population implying the virulent variant present in group VH, and predominating in RNA-seq analysis of temporally
and geographically separate Varroa-infested colonies, was selected upon transmission from Varroa, a conclusion supported
by direct injection of pupae in vitro with mixed virus populations. Identification of a virulent variant of DWV, the role of
Varroa in its transmission and the resulting host transcriptome changes furthers our understanding of this important viral
pathogen of honeybees.
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Introduction
Host-pathogen interactions can be broadly divided into
asymptomatic or symptomatic infections [1]. In the former, the
absence of symptomatic disease is typically due to restricted
pathogen replication, which reduces the opportunities for hori-
zontal transmission within its host population. Conversely,
prolonged survival of the infected host increases the likelihood of
vertical transmission of the pathogen [2]. In contrast, symptomatic
infections are typically characterized by high levels of pathogen
replication, with consequent enhanced virulence, thereby maxi-
mizing horizontal transmission [1–4]. The ‘lifestyle choice’ of
asymptomatic or symptomatic infection is determined by multiple
factors including the duration of host-pathogen co-evolution, host
physiology and anti-pathogen responses, routes of transmission
and environmental factors. Evolutionary changes in pathogen
virulence may be triggered by changes in pathogen-host assem-
blages [5]. In the case of multi-host pathogens with interspecies
transmission, a pathogen’s virulence may increase following
introduction of a second host, when the constraint on pathogen
virulence in a given host is removed [6].
The European honeybee (Apis mellifera) is the predominant
managed pollinating insect and delivers economically important
pollination services for agriculture which are estimated to add
,$40bn globally to crop value/annum [7]. Factors that influence
colony health and viability are therefore important for colony
survival and pollination performance. In addition to the bacterial
foulbroods, the most important diseases of A. mellifera are caused by
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a range of viruses many of which are vectored by the ectoparasitic
mite Varroa destructor when feeding on honeybee haemolymph.
Varroa is believed to have expanded its host range from Apis cerana
to A. mellifera during the first half of the 20th century and
subsequently spread to all beekeeping regions of the world with the
exception of Australia [8–11].
Deformed wing virus (DWV), a picorna-like single-stranded,
positive-sense, RNA virus [12,13], is present in the majority of
honeybee colonies [10]. DWV is closely related to Varroa
destructor virus type 1 (VDV-1) [14]. Their recombinants
[15,16] and Kakugo virus (KV) [17], which together exhibit at
least 84% nucleotide identity, can be considered as strains of the
same virus (henceforth we use the term DWV to refer to this
related group of viruses). In the absence of Varroa, DWV generally
causes asymptomatic infection and is present at low levels in
honeybees. In contrast, in Varroa-infested colonies, mite-exposed
pupae can exhibit very high DWV levels which may result in
impaired development of the teneral adult honeybee and increased
mortality in all honeybees in these colonies, including asymptom-
atic adults [10,13]. The mechanisms underlying the transition of
DWV from a relatively benign virus to a major honeybee
pathogen in the presence of Varroa remain unclear. Two
possibilities, not mutually exclusive, have been proposed: suppres-
sion of honeybee antivirus defences by Varroa mites which allows
the virus to proliferate [18,19], and a Varroa-driven selection of
particular DWV genotypes, potentially due to replication in the
mite [15,20].
Previous studies using functional or gene expression analysis
have produced contradictory conclusions on the impact of Varroa
on the immune responses of honeybees. Initial reports indicated
that Varroa-exposed honeybees were immuno-compromised
[18,19], although later transcriptome analysis found little or no
effect on genes implicated in insect immunity [21,22]. Additional
studies have shown down-regulation of a honeybee NF-kB
transcription factor [23]. Recent reports have implicated the
Drosophila Toll, Imd and Jak-Stat signalling pathways in controlling
RNA virus infection [24] and RNA interference (RNAi), which
has long been considered the major antiviral mechanism in insects
[25], has recently been associated with controlling the persistence
of RNA virus infections in Drosophila [26]. It was therefore possible
that high levels of DWV in Varroa-exposed honeybees could be the
result of a suppression of these antivirus responses and so
warranted further analysis.
We have previously demonstrated that Varroa infestation is
associated with the accumulation in mite-exposed pupae of a
particular subset of DWV-like viruses [15]. These recombinant
forms (RF) are predominantly comprised of genomes with
structural and non-structural coding regions that most closely
align with VDV-1 and DWV respectively. The organisation of
these recombinants suggests that, as with other picorna-like
viruses, DWV likely has a modular genome, with a 59 untranslated
region (59-UTR) driving translation of the structural or capsid (CP)
and non-structural (NS) ‘modules’ [15]. We hypothesised that such
recombinants were transmitted more efficiently between Varroa
and honeybees, resulting in their amplification to the markedly
elevated levels observed in Varroa-parasitized pupae (about 1000
times higher than in unexposed pupae). In recent complementary
studies, changes in the composition of the DWV population over a
large temporal and spatial scale following Varroa infestation were
reported for honeybees colonies following accidental introduction
of Varroa into the Hawaiian islands [20]. The introduction of Varroa
was associated with a marked restriction in DWV diversity
measured in the pooled honeybee samples collected from the
Varroa-infested colonies, although the precise identity of the
dominant virus was not determined [20].
In the present study we devised a novel experimental system to
specifically test two hypotheses on the role of Varroa in the
development of high-level DWV infection in the honeybee,
namely that the mite (i) amplifies and transmits virulent genotypes
of DWV, and (ii) suppresses antiviral responses, including immune
signalling pathways and RNA interference. The experimental
procedure included exposure of Varroa-naı¨ve honeybees to mites
and their associated DWV payload together with the per os in-hive
horizontal transmission. The use of Varroa-naı¨ve honeybees from a
Varroa-free region allowed us to monitor changes in DWV diversity
and loads, as well as potential antivirus responses in the honeybee
responses, following exposure to the viral genotypes associated
with Varroa infestation. Importantly, we analysed immune
responses and viral load/diversity in individual mite-exposed
and –unexposed pupae, rather than in pooled samples. This
allowed us to stratify individual responses into four distinct
experimental groups, characterised by Varroa exposure and viral
load, that clearly correlated with characteristic changes in the
transcriptome and virus population diversity. In addition, we
recapitulated the exposure of Varroa-free honeybees to DWV by
direct injection and analysed virus diversity in bees of a colony
with long-established Varroa infestation.
Our results indicate that a virulent recombinant form of DWV,
while transmissible orally, only replicates to high levels when
directly inoculated into honeybee haemolymph – by Varroa or
experimental injection. This results in massive reduction of DWV
diversity in bees with high virus levels, both in the Varroa-exposed
pupae and newly emerged bees with symptomatic deformed wing
disease. Significantly, the same virulent recombinant form of
DWV reached the highest levels in mite-exposed pupae and in
adult bees exhibiting characteristic deformed wing symptoms.
Although exposure to Varroa resulted in changes in expression of a
number of immune-related genes, the roles of which should be
further explored, we demonstrate that it is the route of virus
acquisition that is responsible for the amplification of this virulent
form of DWV in a Varroa-infested colony.
Author Summary
Honeybees are the most important managed pollinating
insect, contributing billions of dollars to annual global
agricultural production. Over the last century a parasitic
mite, Varroa, has spread worldwide, with significant
impacts on honeybee colony health as a consequence of
its transmission of a cocktail of viruses while feeding on
honeybee ‘blood’. The most important virus for colony
health is deformed wing virus (DWV), high levels of which
cause developmental deformities and premature ageing
resulting in high overwintering colony losses. In experi-
ments on individual Varroa-exposed pupae we demon-
strate that a single type of virulent DWV is amplified 1,000–
10,000 times in the recipient pupae, despite the mite
containing a high diversity of replicating DWV strains. We
could recapitulate this by direct injection of pupae with
mixed virus populations, showing the virulent strain is
advantaged by the route of transmission. In parallel, we
detected changes in the immune response and develop-
mental gene expression of the honeybee and propose that
these contribute to the characteristic pathogenesis of
DWV. Identification of a virulent strain of DWV has
implications for therapeutic or prophylactic interventions
to improve honeybee colony health, as well as contribut-
ing to our understanding of the biology of this important
honeybee viral pathogen.
Virus Infection in the Honeybee
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Results
Experimental infestation by Varroa mites results in
bimodal DWV levels
Worker honeybee larvae from a Varroa-free colony (sourced
from a region with no historic contacts with or presence of Varroa)
were moved in a frame transfer experiment to a Varroa-infested
colony. The larvae were subsequently exposed through feeding to
DWV strains circulating in the infested colony from day 4 until the
cells were capped at day 9 (all times relative to egg laying; Figure 1,
Treatment 1). Varroa mites enter brood cells immediately prior to
capping. Therefore, pupae located within brood cells that contain
Varroa mites are also subjected to the mite feeding on haemolymph
during pupal development (Figure 1, Treatment 2) until sampling
on day 15 (the purple-eye stage), six days after cell capping.
Feeding of the mites (adult females) on pupae was confirmed by
the presence of at least one protonymph in the capped cell [27].
We assessed the total levels of DWV viruses in 80 individual
pupae by qRT-PCR using a primer pair for a conserved
polymerase-coding region, designed to detect all known DWV
strains, including DWV, VDV-1 and KV (Table S1). The real-
time PCR Ct values showed a clear bimodal distribution, with
distinct low- and high-levels of DWV (p,10216; Figure 1, Figure
S1). Low DWV levels were observed in all (n = 23) sampled pupae
maintained in the Varroa-free colony (group C, ‘‘Control’’), in all
19 sampled pupae transferred to the Varroa-infested colony that
were not capped with a Varroa mite and therefore subjected only to
Treatment 1 (oral DWV infection; group NV, ‘‘No Varroa’’), and in
10 of 33 pupae upon which Varroa mites had fed, Treatment 2
(group VL, ‘‘Varroa Low’’). In contrast, high levels of DWV-like
viruses were detected in the remaining 23 of 33 Varroa-associated
pupae, which experienced both Treatment 1 and Treatment 2
(group VH, ‘‘Varroa High’’). The Ct ranges for the VH group lay
entirely below the VL range, indicating significantly higher virus
levels in VH (Figure S1A) whereas the Ct values in groups C, NV
and VL were statistically indistinguishable (ANOVA, p = 0.5261).
We have previously reported similar proportions of Varroa-
associated pupae with low and high levels of DWV in an
independent (temporally and geographically) study [15]. These
results indicate that direct Varroa exposure does not inevitably lead
to high, presumed pathogenic, DWV levels, as reported previously
[15,28,29], at least when age-matched, synchronously exposed
pupae are analysed individually. The difference in DWV levels
between pupae in the VL and VH groups could not be explained
by different mite loads - both contained an average of 1.375 adult
female Varroa mites per cell (data not shown). These two distinct
classes of Varroa-exposed pupae, and their associated mites, were
included as separate groups in subsequent analyses to investigate
host or parasite determinants that influenced the outcome of
exposure.
We sampled eight honeybee pupae selected at random from
each of the four groups (C, NV, VH and VL; Figure 1) for further
analysis. With the exception of the siRNA responses (for which
pooled samples of each of the four groups were used), subsequent
Figure 1. Design of the frame transfer experiment, summary of treatments, and experimental honeybee groups. Shown are
treatments of the experimental groups of honeybees originated in a single colony, number (n) of individuals, and the results of DWV-like virus
quantification in the individual pupae by real-time PCR (average Ct value 6 standard deviation (SD) and the range of Ct values).
doi:10.1371/journal.ppat.1004230.g001
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analysis of transcriptional responses (microarray transcriptional
profiling) and virus diversity (qRT-PCR, cloning and sequencing)
were conducted individually on each of the eight pupae from the
four response groups.
Significant changes to the honeybee transcriptome are
characteristic of experimental groups and Varroa/virus
exposure
We used a two-colour dye-balanced loop design microarray
[30,31] to determine the genome-wide transcriptional profile using
RNA extracted from the 32 samples defined above, (8 pupae from
each experimental group). The oligonucleotide expression array
contained probes to all protein-coding transcripts of A. mellifera
[32], as well as probes to all known viral and fungal pathogens of
honeybees, including distinct DWV and VDV-1 probes. After
array normalization, differentially expressed (DE) genes were
determined for each contrast between experimental groups
(Figure 2A, listed in Table S2 with commonalities between
contrasts shown in Table S3). Microarray results were validated by
qRT-PCR using oligonucleotide primers to a set of honeybee DE
genes and the constitutively expressed ribosomal protein 49 (Rp49)
gene (GB10903; Table S1), showing strong positive correlations
between the processed microarray signals and normalized Ct
values (Pearson correlation coefficients between 0.504 and 0.873).
Additionally, there was a strong positive correlation between the
DWV microarray signal and qRT-PCR Ct values for DWV-like
viruses using generic DWV primers (Table S1, Primers 59 and 60),
Pearson correlation coefficient 0.797. Other than DWV-like
viruses, no other honeybee pathogens were detected.
There were high levels of commonality and additivity for DE
genes in the contrasts considered (Figure 2A, Figure S2 A, C). For
example, the C to VH contrast (in which,10% of genes were DE)
can be decomposed into two sub-contrasts by exposure regime, i.e.
split C to VH at oral exposure (NV) or at mite feeding (VL).
Similarly the C to VL contrast can be split at NV. These
decompositions exhibit high orthogonality (Figure 2 A,B; Figure
S2 B,C). This suggests that expression of essentially different sets of
genes are influenced following oral exposure to DWV, Varroa
feeding, and the markedly elevated levels of DWV in Varroa-
exposed pupae. To explore this further we conducted principal
component analysis (PCA). Distinct clustering by experimental
group was observed when two independent sets of DE genes with
the lowest p-values were analysed i.e. those from the DE genes
pooled from all contrasts (Figure 2C), or DE genes in each of six
contrasts (Figure S3). Consequently, PCA strongly suggests that
the experimental groups exhibit characteristic gene expression
signatures reflecting their fate after exposure in a Varroa-infested
colony.
To obtain insight into the functional consequences of DE gene
expression we carried out Gene Ontology (GO) analysis, focusing
on the GO Biological Process (BP) [33]. A number of overrep-
resented GO BP terms related to cell division were associated with
DE genes in the C to NV contrast, while those related to
regulation of various cellular processes were associated with the
DE genes in the NV to VL contrast (Figure 2A, Table S4).
Notably, no overrepresented GO BP terms were associated with
the genes DE following increase of DWV levels (VL to VH
contrast). We then looked in detail at the expression patterns of
likely immune-related genes as it had previously been reported
that Varroa and/or viruses could influence honeybee immunity
[18,19,23]. The list of 381 putative honeybee immune-related
genes included those previously published [34,35] together with
honeybee homologs of the Drosophila genes associated with the GO
term ‘‘Immune system process’’ (GO: 0002376). The C to VH and
C to VL contrasts exhibited the highest number of DE immune-
related genes (n= 42 and n = 26 respectively, 22 of the latter also
being in the C to VH contrast), whereas oral exposure (C to NV)
resulted in 18 DE immune-related genes (Table 1, Figure S4).
Independent confirmation of DE of immune-related genes was
obtained by qRT-PCR analysis of persephone protease
(GB14044), Tollo (GB10640), and Vago (GB10896) with Pearson
correlation coefficients of 0.598, 0.504 and 0.692 respectively.
Next generation sequencing analysis of the RNAi
response in DWV-infected pupae
Although no significant changes in expression of genes
associated with the RNAi response (e.g. Argonaute, Dicer) [25]
were observed in the microarray analysis, there could be post-
transcriptional effects on RNAi generation. We therefore analysed
the DWV-related RNAi population and compared it with the
levels and identity of virus in pupae from the four experimental
groups (Figure 1). Small RNA fractions (15 to 40 nt) were isolated
from total RNA samples, pooled according to the experimental
groups and used as templates for Illumina high-throughput
sequencing. One library was generated for the group C honeybees
and two libraries for each of the other groups. These libraries,
each containing 11 to 35 million reads, were aligned to the
reference viral sequences (DWV and VDV-1, GenBank accession
numbers GU109335 and AY251269 respectively; Figure 3), as
well as to the honeybee miRNA sequences [36], using Bowtie [37].
All RNA libraries analysed contained similar proportions of
host-encoded miRNA reads, 12 to 18% of the total (Table S5),
indicating both successful isolation of small RNA libraries and
broad equivalence of the pooled sample sets. DWV- and VDV-1-
specific siRNAs of both polarities were present in all treatment
groups. DWV- and VDV-1-specific siRNAs could originate from
either DWV or VDV-1, or from the previously reported [15]
recombinants between these parental viruses (Figure 3). Approx-
imately 50% of all viral reads were 22 nt in length and 25% were
21 nt, with three to four times the number of sense orientation
reads to antisense, irrespective of the read length (Table S5). To
exclude variation due to the efficiency of library preparation, we
normalised the siRNA number to the total number of honeybee
miRNA reads in a library. The normalised loads of DWV/VDV-
1-specific siRNA reads were similarly low in group C and the two
NV group libraries (0.341, 0.377 and 0.397 siRNA per 1000
miRNAs respectively), ,5 times higher in the two VL group
libraries (1.926 and 2.066 siRNAs per 1000 miRNAs) which
exhibited similar viral loads to groups C and NV (Figure 4A, see
below), but markedly higher in the VH group samples (285 and
287 siRNA per 1000 miRNAs; Table S5). The profiles of the
DWV-and VDV-1-specific siRNA coverage of the DWV and
VDV-1 reference genomes (Figure 3) were most similar between
groups VL and VH (Pearson correlation 0.955 to 0.963 for DWV,
0.945 to 0.962 for VDV-1, Table S6). The profiles for groups C
and NV were more distinct from each other, and to VH or VL
(Pearson correlation 0.593 to 0.786 for DWV, 0.399 to 0.726 for
VDV-1; Table S6).
Significant changes in DWV levels and diversity following
oral DWV infection and Varroa mite feeding revealed by
virus-specific qRT PCR
We and others have previously reported changes in virus
diversity at the population level [20] and the predominance of
particular virus recombinants (i.e. a reduction in diversity) in
honeybee pupae exhibiting high viral loads [15]. To quantify both
viral load and diversity in individual honeybee pupae and their
Virus Infection in the Honeybee
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associated Varroa mites we used generic NS qRT-PCR primers or
primer pairs specific for DWV or VDV-1 CP or NS coding regions
(Table S1). We quantified the total virus levels (Figure 4A) and the
levels of the DWV-type and VDV-1-type CP and NS regions
(Figure 4B) in each of the 32 pupae as well as in each of 15 Varroa
mite samples co-isolated with the VH and VL group pupae.
As already indicated (Figure 1), the qRT-PCR Ct values used to
separate the VH from the VL, NV and C experimental groups,
indicated significant differences in viral loads in representative
pupae (Figure 4A), with the VH group exhibiting at least 3 log10
higher levels of DWV-like viruses per pupa. When analysed using
specific CP or NS primer pairs, the most pronounced difference
was the increase in the number of genomes with the VDV-1 CP
and the DWV NS sequences in the VH group pupae compared to
the other treatment groups (Figure 4B). In comparison with the
control group C, the VH group exhibited a 6,000-fold increase in
the VDV-1 CP region and a 26,000-fold increase in the DWV NS
coding region. When compared with the NV group, the VH group
showed lower relative increases (312-fold for VDV-1 CP and
2500-fold for DWV NS, P,0.0001 in both cases) because
significant amplification of viruses bearing VDV-1 CP- (by 27-
fold [P = 0.0217]) and DWV NS-regions (10-fold [P = 0.0314])
also occurred in the NV group relative to the control group C
(Figure 4B). The dramatic rise of the recombinant genome(s)
containing VDV-1 CP and DWV NS in the VH group was also
accompanied by a statistically significant 30-fold decrease
(P = 0.0151) of the DWV-type CP and 26-fold decrease
(P = 0.0477) of the VDV-1 NS compared with the NV group.
The levels of VDV-1 CP and DWV NS coding regions showed
strong positive correlation (r = 0.9691) suggesting that this partic-
ular recombinant was preferentially acquired or amplified in the
VH group pupae. The Varroa-exposed VL group also potentially
acquired DWV from the mite as well as during larval feeding. It
was therefore interesting to note that, when compared to the NV
group, there was a statistically significant 54-fold decrease of DWV
CP- (P = 0.0057) and a 36-fold decrease of VDV-1 NS-regions
(P = 0.0151) in the VL group. Since both the VL and VH group
pupae were mite-exposed but contained distinct levels and
populations of DWV-like viruses we also characterised the viruses,
and evidence of their replication, in the associated mites to
determine if there was a correlation between high levels of virus in
the honeybee and replication in the mite, as previously reported
[38].
DWV- or VDV-1 specific qRT-PCR analysis demonstrated
only a weak correlation with virus levels in the corresponding
honeybee pupae (Figure S5). The highest correlations were found
for the total load of DWV-like viruses determined using universal
NS primers across the VL and VH groups (r= 0.567). Notably, we
found that correlation between the levels of VDV-1 CP- and
DWV NS-regions (sequences present in the predominant virus
population in Varroa-infested VH group pupae; Figure S5) in the
Varroa mites and the bee pupae were lower, r = 0.403 and
r = 0.465, respectively. We went on to investigate whether we
could distinguish between the mite-associated viruses in the VL
and VH groups on the basis of their ability to replicate (as
determined by negative strand synthesis) in the ectoparasite.
Negative strand RNA was generally low but detectable in 10/15
mites analysed, with no significant difference between the DWV or
VDV-1 CP levels (Figure S6). Together, these observations suggest
that the low levels of DWV-like viruses in the VL group pupae
cannot be explained by corresponding low levels of the virus in the
mite and, similarly, that higher levels of the recombinant virus
genomes in the mite-exposed honeybees (VH group) could not be
attributed to either the preferential replication or absolute levels of
these viruses in the associated mites.
Virus diversity is markedly reduced in pupae but not in
the associated Varroa mites
The dominance of recombinant viruses bearing VDV-1 CP and
DWV NS coding regions in the VH group was strongly suggested
by qRT-PCR (Figure 4B). Since recent studies have demonstrated
that mite infestation is associated with a marked reduction in virus
diversity at the regional scale [20], we extended our analysis to
determine DWV-like virus diversity in individual pupae of the four
exposure groups and, where appropriate, the co-isolated mites. In
parallel, we also sampled random purple-eye stage pupae from the
Varroa-infested colony to determine the pre-existing virus popula-
tion at frame transfer. Nested PCR using generic (outer) and four
specific (inner) primer pairs (Table S1) – for each possible
combination of CP and NS region – was used to amplify a 1.3 kb
fragment spanning a central region of the virus genome
(corresponding to nucleotides 4926–6255 of the DWV genome;
GenBank accession No. AJ489744) containing both CP and NS
coding regions. We noted that no recombinants bearing a DWV
CP region and VDV-1 NS region were detected in any of the
experimental groups. For each of the eight pupae from the four
exposure groups (C, NV, VL, VH), and pupae-associated
individual mites from the VL and VH groups, PCR fragments
were cloned and 8–18 individual clones sequenced. In total, 93
individual sequences were obtained of the 1330 nt. region and
aligned with 12 DWV-like sequences (DWV, VDV-1, KV and
recombinants thereof; see Materials and Methods) to generate a
robust phylogenetic tree (Figure 5) due to the 22.71% sequence
divergence in the region analysed.
The resulting dendrogram contained six distinct clusters, one
each for non-recombinant DWV- or VDV-1-like sequences,
together with four different VDV-1/DWV recombinant forms
(designated RF1–RF4; Figure 5). Individual sequences obtained
from pupae in exposure groups C, NV, VL and the Varroa-infested
colony were present in all the major clusters indicating that these
contain a significant diversity of viruses. In striking contrast, viral
sequences from the VH experimental group exhibited almost no
sequence divergence (0.15% at the nucleotide level), and
consequently all clustered within a single clade (designated
VDV-1/DWV RF4 in Figure 5). Therefore, the reduction in viral
diversity (as previously determined by high resolution melting
analysis) associated with the introduction of Varroa observed at the
scale of tens of colonies exposed to the mite over several years [20]
Figure 2. Summary of the gene expression changes in the experiment. (A) Total number of differentially expressed (DE) genes in the
contrasts. The numbers of up-regulated and down-regulated genes in each contrast are marked, respectively, as q and Q. An up-regulated gene
level is higher at the head of the arrow showing the contrast; commonality is shown in brackets. The numbers of overrepresented GO Biological
Process terms associated with the DE genes are shown in red italic characters for each contrast. (B) A geometrical visualization of the three-stage
experimental process: shown are, with numbers of differentially expressed genes, the ‘‘orthogonal’’ stages, contrasts C to NV (black), NV to VL (red),
VL to VH (blue), and the commonalities in the composite stages shown in the colour of the ‘‘orthogonal’’ contrast. The DE gene numbers in the
composite contrasts without commonalities to the ‘‘orthogonal’’ stages are shown in grey. Commonalities between orthogonal stages are shown in
corresponding colour in brackets. (C) Result of principal component analysis applied to a set 60 DE genes (pooled from all contrasts) with low
adjusted p-values. Shown is a plot of the first two principal component scores for Cy3 and Cy5 replicates for all honeybee samples.
doi:10.1371/journal.ppat.1004230.g002
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Table 1. Differential expression of the honeybee immune-related genes in response to oral DWV and Varroa mite feeding.
BeeBase IDa
Drosophila
homolog IDb Genec
Pathway,
categoryd Fold change in contrast
C to NV C to VH C to VL NV to VH NV to VL VL to VH
GB10896 FBgn0051997 Vago antivir 1.860 1.468 1.833 - - -
GB10640 FBgn0029114 Tollo Toll - 20.452 - - - -
GB17781 FBgn0036494 Toll Toll - 20.215 - - - -
GB15688 FBgn0003495 spatzle Toll - 20.381 - 20.249 - 20.346
GB17879 FBgn0030310 PGRP-S3 Toll - 20.564 - 20.381 - 20.381
GB14044 FBgn0030051 spirit Toll - 20.701 - - - -
GB19582 FBgn0028984 NEC-like Toll 0.482 0.642 0.475 - - -
GB13935 FBgn0261988 Gprk2 Toll - 20.322 20.311 20.323 20.312 -
GB19452 FBgn0243514 GNBP3 Toll 0.800 1.599 0.931 - - -
GB19961 FBgn0040323 GNBP1 Toll - 20.400 20.289 - - -
GB19066 FBgn0260632 dorsal Toll - 0.202 - - - -
GB17654 not found SP45 SP - 20.535 20.669 - - -
GB16214 FBgn0036287 SP38 SP - 20.214 - 20.284 20.236 -
GB14309 FBgn0033359 SP33 SP 1.138 1.277 1.153 - - -
GB11511 FBgn0038595 SP32 SP 1.667 - 1.395 - - -
GB11743 FBgn0035290 AmSCR Scav 0.806 0.511 - - - -
GB10506 FBgn0058006 AmSCR Scav 20.359 20.369 20.350 - - -
GB15155 FBgn0004197 Serrate Notch - 20.422 20.538 - 20.324 -
GB13135 FBgn0014020 Rho1 JNK - 20.343 20.314 - - -
GB12838 FBgn0015286 Ras JNK 20.217 20.302 - - - -
GB19901 FBgn0243512 puckered JNK 0.600 0.441 - - - -
GB12212 FBgn0001297 kayak JNK 0.371 0.371 - - - -
GB12004 FBgn0001291 Jun JNK 0.450 0.471 - - - -
GB16422 FBgn0004864 hopscotch J-ST - 20.204 - - - -
GB19988 FBgn0025827 Lysozyme Immune 20.315 20.498 20.386 - - -
GB18918 FBgn0004606 zfh1 Immune - 0.401 - - - -
GB16457 FBgn0003963 u-shaped Immune - - 20.291 - 20.371 -
GB15719 FBgn0086899 tlk Immune - - 20.254 - 20.259 .
GB13670 FBgn0043550 Tsp68C Immune 20.708 21.267 20.881 - - -
GB12465 FBgn0003896 tailup Immune - 20.455 20.300 - - -
GB11411 FBgn0004837 Su(H) Immune - 20.214 20.257 - - -
GB12280 FBgn0039141 spastin Immune - 20.318 - - - 20.261
GB16613 FBgn0011823 Pendulin Immune 20.276 20.312 20.297 - - -
GB12373 FBgn0010247 Parp Immune 20.241 20.420 - - - -
GB10718 FBgn0085432 pangolin Immune - 20.230 20.223 - - -
GB17628 FBgn0262738 norpA Immune - 0.266 - - - -
GB12005 FBgn0004657 mys Immune - - - 0.255 - 0.251
GB10124 FBgn0013576 mustard Immune - 20.264 20.281 20.502 20.519 -
GB13202 FBgn0040324 Ephrin Immune - 20.336 20.295 - - -
GB19881 FBgn0027066 Eb1 Immune - . 20.208 - 20.201 -
GB12454 FBgn0243514 eater Immune - 1.555 . - - -
GB13459 FBgn0031464 Duox Immune 0.791 0.619 0.498 - - -
GB19168 FBgn0011764 Dsp1 Immune 20.222 20.355 20.216 - - -
GB14446 FBgn0259099 dcx-emap Immune - 20.440 - 20.679 - -
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is reflected at the level of individual honeybee pupae following
exposure to Varroa for 6 days.
One interpretation of the near-clonality of viral sequences in the
VH group was that these were the only ones carried, and hence
transmitted, by the mite. However, with the exception of the non-
recombinant DWV cluster, which was not detected in the mite,
the 32 viral sequences obtained from Varroa were widely
distributed within the dendrogram (open symbols in Figure 5).
These results imply that, with the possible exception of non-
recombinant DWV, Varroa is capable of acquiring and maintaining
a diversity of DWV-like viruses, but that – either during or
following transmission to naı¨ve pupae – only a subset of these (RF4
in Figure 5) are amplified to the very high levels observed in the
VH group. Since the obvious difference between the horizontal
transmission of DWV per os (larval feeding) and by Varroa is that the
latter involves direct inoculation of virus to the haemolymph in
pupae we investigated the recapitulation of this process by direct
injection of pupae in vitro.
Inoculation of honeybees by injection into haemolymph
results in preferential amplification of specific VDV-1/
DWV recombinants
We directly injected white eye pupae (day 12–13 of develop-
ment) maintained in vitro (as described in [39]) with virus particles
purified from groups C, NV and VH pupae as described
previously [15]. As before, we determined the proportion of the
DWV- and VDV-1-type CP coding regions in the inocula and
injected pupae (following incubation to the purple-eye stage for 3
days) by qRT-PCR using strain-specific primers to the CP and
universal primers to the NS region. Virus preparations from
groups NV and VH contained higher and broadly similar levels of
VDV-1-like CP coding regions. The amount of DWV-like CP
coding regions was much higher in the virus preparation from the
group C pupae (where it accounted for ,12% of the population)
than from either the NV or VH group pupae (Figure 6A). Pupae
inoculated with buffer alone exhibited no significant increased
accumulation of DWV-like viruses when compared with untreated
pupae (Figure 6A). In striking contrast, irrespective of the source of
viral inocula, pupae directly injected with virus preparations
exhibited high virus levels characterised by markedly amplified
VDV-1-like CP coding regions when compared to DWV-like CP
sequences (Figure 6A). Directly injected pupae were therefore
similar, in both DWV-like virus levels and identity, to those
previously observed in the VH experimental group (Figure 4A and
Figure 1).
We additionally conducted next generation sequencing (Illu-
mina paired-end reads) to comprehensively characterise the group
C inocula and the viruses present in pupae injected with the group
C virus. The composition of the inoculum, as determined by qRT-
PCR and subsequent MosaicSolver [40] analysis of the NGS
reads, were in close agreement and consisted of 12.5% DWV (in
excellent agreement with the qRT-PCR-determined level, see
above), 42% VDV-1 with the remainder being VDV-1 CP-
encoding recombinants with a DWV-like NS region (Figure 6B).
Three days after injection, the pupae inoculated with group C
virus exhibited a marked reduction in the DWV content (from .
12% to 1%) and a concomitant increase in recombinant forms of
the virus (70% of the total) that were characterised by the presence
of VDV-1 CP coding region and DWV-like NS regions
(Figure 6B). These results further support our previous conclusion
that DWV-like viruses bearing VDV-1 CP coding regions, and
particularly recombinant forms with DWV-derived NS coding
regions [15], have a selective advantage in Varroa-infested
honeybee colonies, and additionally indicate that this advantage
is manifest after transmission of the virus by direct inoculation and
is not dependent upon Varroa per se.
Independent verification of DWV diversity reduction by
deep sequencing of the honeybees from a Varroa-
infested colony
The sequence analysis of DWV in Varroa-exposed pupae
(Figure 5) in the frame-transfer study supported the presence of
a single, near-clonal, recombinant form of the virus in VH group
honeybees. To formally exclude a role for PCR-biased amplifica-
tion in this result and to extend our analysis to investigate virus
diversity in independent samples (geographically and temporally),
including asymptomatic and symptomatic newly emerged workers,
we investigated virus diversity using next generation sequencing
(NGS). We sampled individual adult nurse worker bees, both
asymptomatic and exhibiting the obvious wing deformities and
abdominal stunting characteristic of DWV disease, from a
naturally Varroa infested colony. We additionally investigated virus
diversity in purple-eye stage pupae to which we had injected (at
the white-eyed stage 3 days previously) virus purified from pupae
from the same colony a month earlier. Analysis was conducted on
individual pupae using a high-throughput RNA-seq approach [41]
with an mRNA protocol which allowed unbiased detection and
quantification of all poly(A) containing RNA, this would include
both host mRNA and the polyadenylated DWV-like genomic
RNA [12].
Table 1. Cont.
BeeBase IDa
Drosophila
homolog IDb Genec
Pathway,
categoryd Fold change in contrast
C to NV C to VH C to VL NV to VH NV to VL VL to VH
GB17018 FBgn0087011 CG41520 Immune 0.499 0.461 0.503 - - -
GB14317 FBgn0021764 sidekick IG - 20.215 - - - -
GB19895 FBgn0003117 pannier GATA - 20.760 20.512 - - -
aHoneybee gene ID according to the Apis mellifera Official Gene Set 1 [30]. Honeybee immune-related genes included in the analysis were either those described in [33]
or the honeybee homologues of the Drosophila melanogaster genes associated with Gene Ontology Biological Process term ‘‘Immune System Process’’ GO:0002376.
bDrosophila melanogaster homologue showing highest similarity in BLAST.
cDrosophila melanogaster gene name according to FlyBase.
dPathway or category of gene if known (Toll - Toll signalling pathway; SP - serine protease; Scav - Scavenger receptor A; Notch - Notch signalling pathway; JNK - JNK
signalling pathway; J-ST - JAK-STAT signalling pathway; IG - IG Superfamily Genes; GATA - GATA transcription factor), Immune - Immune system process gene.
doi:10.1371/journal.ppat.1004230.t001
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The NGS reads were aligned to reference DWV and VDV-1
sequences (GenBank Accession numbers GU109335 and
AY251269 respectively), and the pileup profiles were analysed.
The proportions of DWV and VDV-1 reads in the libraries (each
containing about 10 million reads) showed a bimodal distribution
and were either very high (from 7.41% to 83.87%, Figure 7A
horizontal axis) for injected pupae and symptomatic nurse bees, or
about a thousand fold lower (0.04% to 0.11%) for Varroa-naı¨ve
control pupae, for pupae inoculated with buffer alone and for
asymptomatic nurse bees from the Varroa-infested colony
(Figure 7A, Table S7). The remaining reads were of honeybee
mRNAs. Distribution of the reads with similarity to DWV and
VDV-1 suggested that all samples, irrespective of viral load,
contained recombinant viruses with the CP derived form VDV-1
and NS region derived from DWV, as described above and in
previous studies [15,16]. To assess virus diversity, we calculated
Shannon’s diversity index [42] for the aligned NGS reads from
each experimental pupa or adult bee. Despite the ubiquitous
presence of recombinant DWV-like genomes (all consisting of a
VDV-1 capsid and DWV non-structural coding regions) there was
a striking reduction of virus diversity in the bees and pupae
exhibiting high virus loads (Figure 7A,B,C). Average Shannon’s
diversity index for the NS and CP regions of the viral genomic
RNA were significantly higher in the samples tested with low virus
levels compared to those with high virus levels (0.1% level Fishers
LSD test). At the same time, we observed no significant differences
in Shannon’s diversity index for NS and CP regions at the 5%
level (Fisher LSD test) within the low virus group which consisted
of Varroa-naı¨ve control pupae, pupae injected with buffer alone,
and asymptomatic nurse bees from a Varroa-infested colony (Figure
S7 A, B). For the samples tested with high virus levels (pupae
injected with virus in vitro and symptomatic nurse bees from a
Varroa-infested colony), no differences were observed at the 5%
level (Fisher LSD test) for the NS region. Indeed, combined low
virus level and high virus level groups showed significant
differences in Shannon’s diversity index values for the CP and
NS regions even at the 0.1% level (Figure 7B,C). For comparison
we determined Shannon’s diversity index for a sample prepared by
in vitro transcription of two full-length DWV cDNA clones,
GenBank accession numbers HM067437 and HM067438 [15],
mixed, post transcription, at a known ratio and used as a template
for NGS. We additionally used this control sample to determine
the component of the observed diversity that was attributable to
NGS sequencing errors which we quantified at about 0.5%,
similar to that previously reported [43]. We calculated the
threshold Shannon’s diversity, a 95% confidence limit for clonal
input RNA library (shown as dashed line in Figure 7A) using the
approach described in Text S1 and (Wood et al., unpublished
data). Remarkably, while the diversity index of all samples with
low DWV levels (control and buffer-injected pupae, and asymp-
tomatic nurse honeybees) were well above this threshold, diversity
values of samples with high DWV levels (virus-injected pupae and
symptomatic nurse honeybees) were either very close or below this
clonality threshold. Similar results were obtained when diversity
was estimated using multiple sampling as described in Material
and Methods (Figure S7). In this case the clonality threshold value
(the range shown with the dotted lines in Figure S7) was also
almost indistinguishable from the diversity present in symptomatic
nurse bees from the Varroa-infested colony indicating that the
diversity in these honeybee samples was close to the limit of
detection using NGS analysis. This reinforces the near-clonal
nature of the virus population in Varroa-exposed symptomatic
nurse bees and is in good agreement with the sequence analysis of
VH group pupae following PCR amplification of the central
region of the virus genome (Figure 5). To further explore the near-
clonal nature of the virus population in symptomatic nurse bees
from a Varroa-infested colony we used a pair of flanking primers to
the DWV-like genomic RNA to amplify and clone full-length viral
cDNAs from these samples (GenBank accession number
KJ437447). The central 1330 nt. region of this clone was identical
to that previously characterised from VH group pupae (Figure 5)
despite being sampled from a separate colony in a different apiary
over two years later. The consensus viral sequences, which were
assembled from the NGS libraries from symptomatic honeybees
with high DWV levels, showed highest overall identity with the
full-length clone KJ437447 (specifically 99.15% [SD = 0.31%]
nucleotide and 99.78% [SD = 0.09%] amino acid identity) and the
1330 nt. sequences from VH group pupae, e.g. JX661656 (98.84%
[SD = 0.57%] nucleotide and 100.00% amino acid identity; Table
S7). In respect to the samples with low DWV levels, we found that
Shannon’s diversity index for the NV group sequences (Varroa-free
orally infected pupae; Figure 5) was 0.04172. This value was very
close to the Shannon’s index values in the same genomic region for
the pupae exhibiting low virus levels from the Varroa-infested hive,
0.03623, SD = 0.00026, for control (i.e. not injected) pupae
(0.03929, SD = 0.00097) and for pupae injected with buffer alone
(0.03929, SD = 0.00097); Figure S7 C).
Discussion
The introduction and global spread of the parasitic mite Varroa
destructor in honeybees (Apis mellifera) has had significant impact on
the health and survival of infested colonies [8,13]. Colony losses
associated with Varroa are predominantly attributed to the RNA
virus payload vectored by the parasite and transmitted when the
mite feeds on honeybee haemolymph [10,44]. Although Varroa
were reported to vector at least 5 RNA viruses, the picorna-like
Iflavirus deformed wing virus (DWV) is of particular interest and
importance; deformed wing disease is associated with mite
infestation [9] and high levels of DWV exacerbate overwintering
colony losses [10]. Furthermore, of the viruses analysed, only
DWV levels increased upon introduction of Varroa to Hawaii [20].
Here we show that virus levels exhibited a bimodal distribution in
developing honeybee pupae – low in the absence but generally
high following mite exposure – with high viral levels associated
with emergence of a distinct recombinant form of the virus. This
complements observations of the effects of the introduction of
Varroa at the regional scale (e.g. Hawaii), which is associated with a
dramatic reduction in DWV variation and the emergence of
dominant strains over a scale of months or years [20]. Our study
also strongly suggests that DWV is widespread and present in all
UK honeybees, in Varroa-free and Varroa-infested colonies. By
using different molecular approaches including RNA-seq, cloned
cDNA sequencing and qRT-PCR, we demonstrated that, contrary
to the recently reported figure of 36% DWV presence in the UK
honeybees [45], DWV was present in all n = 250 tested honeybees,
including those from a Varroa-free region (n= 47) (Figure S1 and
data not shown), in line with previous studies from our group [15]
and other [46]. Striking differences in reported DWV incidence
might be due to differential sensitivity of the primers used in these
studies, especially in the honeybees with low DWV levels, which
have higher genetic diversity (Figures 5, 7).
To better understand the interactions of the honeybee host,
Varroa and DWV that account for the observed emergence of
presumed pathogenic, near-clonal strains of the virus we analysed
events at the level of individual honeybee pupae. We reasoned that
the large scale global, temporal and population changes observed
reflect the cumulative outcome of interactions that occur at the
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level of individual pupae within the colony. We further reasoned
that analysis at this level would allow two hypotheses accounting
for the high levels of overt deformed wing disease beekeepers
associate with heavy Varroa infestation to be tested. These
hypotheses, themselves not mutually exclusive, are that; a) Varroa
suppresses the antiviral honeybee defences so allowing unrestricted
DWV replication and b) the presence of Varroa results in the
selection and transmission of particular pathogenic variants of
DWV, resulting in serial amplification within a mite infested
colony. We tested these hypotheses by transferring honeybee
larvae from a Varroa-free to an experimental Varroa-infested
environment, stratified pupae of a standardised age in terms of
mite-exposure and viral load, and investigated transcriptome and
RNAi responses of the host and the virus population in individual
mites and associated pupae.
We demonstrated that Varroa-naı¨ve honeybee larvae (group C)
transferred into a Varroa-infested colony (effectively mimicking the
exposure to oral and mite-transmitted DWV during larval and
pupal development) can, after incubation for 6 days, be stratified
into three distinct pupal groups by Varroa exposure (presence or
absence) and DWV level (high or low). High virus levels were not
observed in the absence of Varroa. Group NV comprised pupae
from capped cells free of Varroa. As Varroa enters the cell
immediately prior to capping [27], we assume this group only
acquired viruses per os during larval feeding. The VH and VL
groups contained Varroa within the capped cell with evidence of
Figure 3. High-throughput sequencing of the honeybee small RNA libraries. The graphs show depth of coverage at the genomic loci of
DWV (red) and VDV-1 (blue). A statistical summary of the reads is given to the right of each group. Only reads unambiguously aligning to DWV or
VDV-1 were used (GenBank Accession numbers GU109335 and AY251269 respectively) with no mismatches being tolerated in the 18 nt. seed.
doi:10.1371/journal.ppat.1004230.g003
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Varroa feeding on the pupae – including nymphal forms present
and signs of abdominal piercing. These groups of pupae harbour
strikingly different DWV populations: the VL group having low
viral levels and high diversity that are not significantly different
from the C and NV groups, whereas the VH group carries 1,000–
10,000 times the viral loads of a single phylogenetic type (Figure 5).
We compared the transcriptome and virus-specific siRNA pool
between the four exposure groups, the virus level and diversity in
associated mites and determined the consequences of direct virus
injection to experimentally test the two proposed hypotheses
accounting for the observed dominance of particular virulent
strains of DWV in the presence of Varroa. We additionally
characterised virus sequence and diversity in injected pupae and
independent naturally Varroa-infested colonies.
Transcriptome changes in response to DWV and Varroa
mite feeding
Previous analyses of transcriptome or immune response changes
in Varroa-exposed honeybees have produced contradictory results,
perhaps due to the analysis of pooled individuals and/or pupae of
different ages. These confounding influences may have obscured
the marked changes in gene expression that we observed in
response to either mite or viral pathogens, as emphasised by the
transcriptome differences observed in the Varroa-associated pupae
in groups VL and VH, which respectively exhibited 493 (,5% of
transcriptome) and 951 (,9%) significantly differentially expressed
(DE) genes when compared with the control group C (Figure 2A).
By stratifying Varroa-exposed pupae by viral load we can
provisionally define transcriptome changes resulting from mite-
associated activities such as wounding, feeding and exposure to
salivary peptides (the 444 genes shared by VL and VH groups) and
those triggered by the high viral load (.3 log10 higher in VH than
VL; Figure 2A). We acknowledge that the C to VL contrast may
include genes involved in suppressing high levels of mite-
transmitted DWV accumulation, an interpretation that warrants
further study. The NV, VL and VH pupal groups also acquired
DWV during larval feeding in the Varroa-infested colony, which on
account of the preferential amplification of particular recombinant
forms of DWV (Figure 4B, discussed further below and [15])
contains a distinct virus population, the composition of which
differs from historically Varroa-free control colonies. Transcriptome
comparison between the C and NV groups showed significant
changes in a large number of genes (416, ,4% of transcriptome),
many of which were also altered in the C to VL (220) and C to VH
(385) contrasts (Figure 2A, B). These may reflect per os exposure,
and the resulting responses to the particular virus population
circulating in the Varroa-infested hive, which resulted in changes of
DWV strain composition in NV compared to C (Figure 4B),
together with changes resulting from environmental differences
(such as circulating pheromone) between the originating and test
colonies which would be common to all three exposure groups.
The set of 59 genes DE in the contrast NV to VL (exposure to
Varroa feeding at the pupal stage which did not result in elevated
viral loads), was largely different from the DE genes in contrast C
to NV with only one gene shared. At the same time, the NV to VL
set showed high commonality with the DE genes in the contrasts C
to VH, C to VL, and NV to VH (34, 51, and 27 genes respectively;
Figure 2A, B). Observed DE gene commonality in the contrasts
was consistent with an orthogonal expression pattern (Figure 2B)
following treatments (Figure 1), with different sets of genes DE in
response to per os infection (C to NV), exposure to mite feeding
(NV to VL), and high DWV (VL to VH) (Figure 2B).
Figure 4. Total and strain-specific virus genome quantification in honeybee pupae. Quantification of the viral RNA by qRT-PCR in the
honeybee pupae from the frame transfer experiment. Numbers of the viral RNA molecules per pupa (n= 8 for each experimental group) are shown.
(A) Total DWV-like virus load quantified with the primers recognising the NS region of all DWV-like viruses (DWV, VDV-1, recombinants thereof and
KV). (B) Quantification of the DWV CP, DWV NS, VDV-1 CP, and VDV-1 NS with the specific primers. Bars show mean value with standard error (SE).
Letters above the bars represent statistically significant groupings according to pairwise t-test comparisons, p,0.05; asterisk marks p,0.0001.
doi:10.1371/journal.ppat.1004230.g004
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Gene Ontology (GO) analysis gave additional insights into the
transcriptional responses in honeybees following experimental
treatments (Figure 1). It has been demonstrated that genes
associated with the same GO terms are likely to have the same
transcription factors binding to their promoter regions, which may
result in co-regulated expression of these gene sets [47]. Therefore,
statistically significant overrepresentation of GO BP terms
associated with the DE genes may suggest coordinated and
distinct honeybee responses to per os exposure (C to NV contrast)
and to Varroa and/or Varroa-injected virus (NV to VL contrast)
(Figure 4A, Figure S1). Such coordinated transcriptional responses
may include genes involved in suppression of virus replication in
the NV and VL group pupae (Figure S1), which will require
further analysis. In contrast to this situation, the transcriptional
changes specifically associated with the increased virus levels in
group VH (VL to VH contrast) had no significantly over- or
under-represented GO BP terms (Figure 2A, Table S4). This
suggests that honeybees did not respond in a coordinated manner
to the increased virus load, and that presumably unrestricted
DWV replication caused dysregulation of transcription and/or
mRNA stability in the honeybee similar to that previously reported
in picornavirus infection of mammalian cells [48–50].
Changes in expression of immune-related genes
We analysed changes in expression of known and presumed
immune-related genes (Table 1, Figure S4) defined previously
[34,35] and by gene ontology (GO) terms associated with
Drosophila homologs [33]. In particular, a number of proposed
components of the Toll signalling pathway were affected, although
the lack of activation of the antimicrobial peptide genes suggested
that no activation of the Toll and Imd pathways had occurred
[34,35,51]. In contrast to both the Varroa-exposed groups (VL and
VH) the NV group was the only group in which there were more
up- than down-regulated immune-related genes when compared
with the control (Table 1, Figure S4). The majority of the changes
seen in the C to NV contrast were also seen in the groups that
acquired DWV both orally and via Varroa (C to VH, C to VL
contrasts), implying that Varroa exposure may exert a dominant
immunosuppressive influence over any up-regulation observed
following oral exposure alone. Significantly enhanced expression
of the honeybee orthologue of Vago (GB10896; Table 1), a
secreted protein upregulated in Drosophila and Aedes following
detection of viral dsRNA by Dicer during virus infection [52,53],
was observed in all groups exposed to oral DWV in the Varroa-
infested colony (NV, VL and VH) when compared with group C.
Varroa exposure (VL or VH groups) resulted in down-regulation
of several putative components of the honeybee Toll signalling
pathway [51], including two Toll receptor orthologs (GB10640,
GB17781), CLIP-domain protease spirit (GB14044) and the Toll
receptor ligand spatzle (GB15688). In addition, spatzle was down-
regulated when the VH group was compared against the other
experimental groups, suggesting down-regulation of this gene may
be a response to the elevated virus levels in the group VH, rather
than the presence of Varroa per se. Toll signaling pathways are
implicated in antiviral resistance to the RNA virus Drosophila
virus X [54], possibly controlling proliferation of haemocytes
which, because of their involvement in phagocytosis, play a central
role in insect immunity [54,55]. We also observed down-regulation
of a Tetraspanin 68C (Tsp68C) ortholog (GB16002, GB13670), a
cell surface membrane scaffolding protein previously implicated in
receptor modulation during hemopoiesis [56], an ortholog of
pannier (GB19895), a GATA transcription factor required for
differentiation of plasmatocytes (which resemble the mammalian
macrophage lineage [57]), and a serrate ortholog (GB15155), a
membrane ligand for the Notch receptor implicated in differen-
tiation of haemocyte-related crystal cell precursors which function
in pathogen defence via melanisation [58]. These transcriptome
changes may help explain functional studies in which salivary
secretions from Varroa mites damage moth caterpillar haemocytes
[59] and suggest that Varroa-mediated depletion of haemocytes, a
key component of the immune response of insects [60–62], may
contribute to enhanced susceptibility to DWV and other viruses.
Interestingly, we also observed suppression of the Friends-of-
GATA transcription factor U-shaped (ush) ortholog (GB16457), in
the C to VL and NV to VL contrasts. Drosophila ush is reported to
antagonise crystal cell development [63,64], implying that the low
level of virus accumulation in the VL group may be due to
elevated numbers of crystal cells resulting from ush down-
regulation.
Although by definition descriptive, transcriptome analysis of
pupae stratified according to Varroa and virus-exposure, also
provides direct insights into possible pathogenic mechanisms. In
the contrast C to VH we observed differential expression of
orthologs of five Drosophila homeobox genes (summarised in Table
S8) encoding transcription factors which are involved in insect
development [65]. Most of these DE genes are reported to be
expressed at early pupal stages and involved in abdomen
(Abdominal B), appendage (apterous) or brain development
(extradenticle). This may explain previously reported develop-
mental abnormalities in the honeybee that are associated with high
DWV levels at the pupal stage [13] and warrant further
investigation to potentially determine the molecular mechanism
underlying DWV pathogenesis.
RNAi responses to DWV in Varroa-infested pupae
Notwithstanding the absence of significant changes in gene
expression of key components, such as Dicer and Argonaute, of
the RNAi response – the major antiviral mechanism in insects [25]
– we explored the relationship between DWV-like virus levels and
the corresponding siRNA populations. In particular, we sought to
investigate if high levels of DWV in VH honeybees was associated
with the limited accumulation of virus-derived siRNA, implying
Figure 5. Phylogenetic analysis of the central region of DWV-like virus genome. PCR amplified cDNA was cloned and sequenced through
the region corresponding to positions 4926 to 6255 of the DWV genome (GenBank Accession number AJ489744). The tip labels include GenBank
accession numbers and are prefixed as follows: C, NV, VL, VH denote the corresponding honeybee pupae treatment group; Varroa-VH and Varroa-VL
indicate sequences from Varroa mites associated with groups VH and VL respectively; ‘‘Infested-colony’’ denotes sequences derived from pupae from
the Varroa source colony; DWV, VDV-1, VDV-1-DWV-Rec followed by a place name indicate reference DWV, VDV-1 and VDV-1-DWV recombinant
sequences present in GenBank. Sequences derived from the group VH honeybee pupae are highlighted with arrows and sequences from Varroa
mites associated with groups VH and VL are indicated with filled or empty squares respectively. Alignments were performed using CLUSTAL [77], and
the neighbour-joining trees were produced and bootstrapped using the PHYLIP package [78]. Numbers at the nodes represent bootstrap values
obtained from 1000 replications shown for the major branches supported by more than 750 replications. The length of branches is proportional to
the number of changes. RF1 to RF4 indicate the distinct DWV/VDV-1 recombinant forms as defined by similarity to reference DWV and VDV-1
sequences (GenBank Accession numbers GU109335 and AY251269 respectively) in the CP and NS regions of the sequence., DWVV indicates virulent
form of DWV.
doi:10.1371/journal.ppat.1004230.g005
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the virus may express an siRNA suppressor as, for example,
demonstrated in Alphavirus infection of mosquitos [66]. Although
DWV- and VDV-1 specific siRNAs were recently detected in
adult honeybees [67,68], these studies could not show if RNAi is
involved in suppression of the virus, because viral genomic RNA
levels were not quantified. Analysis of siRNAs in the honeybees of
the frame transfer experiment showed that the predominant
DWV- and VDV-1-specific siRNAs were 22 nt in length with
genome sense strand-specific siRNAs present at a 3–4 fold excess
over antisense. This was consistent both with the presence of
replicating DWV-like viruses in all experimental groups and with
the known activity of Dicer in other insects [25] and strongly
suggests normal functioning of Dicer in honeybees [69]. As insects
do not amplify siRNA populations [25], it was unsurprising that
virus-specific siRNA levels were broadly proportional to the level
of viral genomic RNA determined by qRT-PCR; the C and NV
groups exhibited ,103 times less viral genomic RNA than the VH
group and normalised siRNA levels differed by ,770 times (Table
S5). The exception to this was the siRNA response in the VL
group which was ,5 times higher proportionally than the level of
VL virus genomic RNA (Table S5). The relationship between the
levels and compositions of the viral genomic RNA and virus-
derived siRNA may be altered by differences in targeting of the
individual components of DWV-like virus population by the
honeybee RNAi machinery, as observed during West Nile virus
infection of mosquitos [70]. Although the presence of virus-specific
siRNAs does not necessarily correlate with effective silencing –
viruses may encode late-acting suppressors such as the Argonaute-
inhibiting 1A protein of cricket paralysis virus [71] – the robust
siRNA response in the VL group may contribute to suppression of
Figure 6. Changes in the strain composition of DWV complexes in honeybee pupae following direct injection of virus. Levels of the
DWV- and VDV-1 CP-coding RNA determined by qRT-PCR (left panel) in the virus preparations used for injection, and (right panel) in pupae following
incubation for 3 days. (A) Left panel: DCt values for the DWV-type and VDV-1-type CP were obtained by subtracting Ct values for the corresponding
CP from Ct for the total DWV-like viruses quantified using ‘‘Universal’’ primers to the NS gene. Right panel: Ct values for the DWV-type and VDV-1-
type CP. Six pupae were used for each virus-injected group, three pupae were used for each of the buffer-injected and non-injected control groups.
Bars show mean value with standard error. Letters above the bars represent statistically significant groupings according to pairwise t-test
comparisons for VDV-1 CP (p-value ,0.01). (B) High-throughput sequencing of the virus preparations from the honeybees of group C (left), and the
virus accumulated in the pupae injected with 20 ng of the virus preparation (right), 3 days post injection. The graphs show depth of coverage at
genomic loci in DWV (red) and VDV-1 (blue) determined by high-throughput sequencing of viral RNA aligning to the DWV and VDV-1 sequences
(GenBank Accession numbers GU109335 and AY251269 respectively). Only reads unambiguously aligning to DWV or VDV-1 sequences were used,
with up to 3 mismatches tolerated in the 18 nt. seed region. The percentages of DWV, VDV-1 and the DWV-VDV-1 recombinants predicted by
MosaicSolver [40] are shown below. The pileup graphs for DWV and VDV-1 are shown, respectively, in red and dark blue. The CP-coding region of the
virus C preparation and the virus C-injected pupae, which shows a decrease of DWV coverage compared to the injected virus, is highlighted in yellow.
doi:10.1371/journal.ppat.1004230.g006
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DWV replication and the differences between this response and
that observed in the VH group may be a fruitful area for further
analysis.
Genetic diversity of the DWV population is determined
by route of transmission rather than preferential
amplification of virus in Varroa
The introduction of the parasitic Varroa mite elevates the level of
DWV-like viruses [20], amplifies particular strains that that are
best defined as recombinant forms (RF) bearing the capsid
determinants of VDV-1 and non-structural genome region from
DWV [15,16] and dramatically reduces the diversity of DWV-like
viruses in a population [20]. Using complementary approaches
including strain-specific qRT-PCR and sequencing together with
next generation sequencing of the virus genome and host siRNA
response to infection, we analysed individual pupae exposed to
DWV during larval feeding and following mite exposure, and
recapitulated horizontal transmission of virus by Varroa using direct
injection.
The C, NV and VL exposure groups all carried low viral loads
and exhibited high virus diversity (Figure 4B, Figure 5). However,
the virus populations carried were distinct, with the NV and VL
experimental groups containing a diverse range of recombinant
forms of DWV-like viruses bearing the capsid coding region of
VDV-1 and the non-structural coding regions of DWV. In
contrast, the VH group exhibited very high levels of a specific
near-clonal (0.15% divergence in the regions sequenced) recom-
binant form of DWV (labelled RF4 in Figure 5). Due to the
subsequent identification of the same near-clonal virulent virus in
temporally and spatially distinct samples (see below) we henceforth
designate this virus DWVV to discriminate it from other
circulating recombinants forms. This suggests that the changes
reported in virus levels and diversity at a regional scale [20] reflect
events occurring within a few days (uncapped to the purple-eye
stage) in individual mite-exposed pupae. Nearly identical, cluster-
ing tightly within the DWVV clade, were also detected in pupae
from the C, NV and VL groups (Figure 5). Since these groups have
significantly lower viral loads it implies that the high viral loads
seen in the VH group cannot be solely attributed to their infection
with a particular recombinant form of the virus.
We reasoned that there were two possibilities that might
account for the marked amplification of DWVV in the VH group
pupae. Firstly, the mite may have delivered a high dose of one
specific recombinant form, perhaps reflecting its preferential
replication in the ectoparasite. Secondly, we considered that
DWVV might have a growth advantage when inoculated into
haemolymph by Varroa (potentially in addition to the preferential
amplification in the mite). To distinguish between these possibil-
ities we sequenced qRT-PCR amplified viral RNA from mites co-
isolated from capped cells containing group VL and VH pupae.
We also investigated the consequences of Varroa-independent
mechanical virus transmission by direct injection of mixed virus
preparations to Varroa-naı¨ve pupae and subsequent monitoring of
virus levels and diversity.
Individual Varroa mites contained a diversity of DWV-like
sequences that were well distributed throughout the phylogenetic
tree of virus sequences from pupae (square symbols, Figure 5).
Figure 7. DWV diversity and the level of DWV accumulation. (A) Average Shannon’s diversity Index (corrected for NGS sequencing error, as
described in Text S1 and (Wood et al., unpublished data) across the NS region, plotted against the proportion of DWV and VDV-1 reads. The error bar
associated with each point is a 95% confidence interval for averages produced in this way. (B, C) Shannon’s diversity index for all honeybees with low
virus levels (groups ‘‘Control pupae’’, ‘‘Buffer-injected pupae’’ and ‘‘Asymptomatic nurse honeybees’’) and for the honeybees with high virus levels
(groups ‘‘Virus-injected pupae’’ and ‘‘Symptomatic nurse honeybees’’), (B) for the NS region and (C) for the CP region positions in the DWV reference
genome, GenBank Accession number AJ489744, are 5008 to 9826 and 1751 to 4595 respectively. A 95% confidence interval for clonal input RNA
library is shown as dashed line at 0.012. The sets of diversity values in (B) and (C) are significantly different, Least Significant Difference (LSD) test at
0.1%.
doi:10.1371/journal.ppat.1004230.g007
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Using VDV-1- and/or DWV-specific primer pairs spanning the
central 1.3 kb region of the virus genome mites were detected
containing VDV-1 and all four distinct RFs identified in the four
experimental groups in the frame transfer study. Only non-
recombinant DWV was absent from the 32 mite-associated viruses
sequenced. We also detected negative strand sequences of both
DWV and VDV-1 CP regions in the majority of the 15 mites
tested (Figure S6), implying that virus replication does occur in the
mite. Although we did not detect DWV CP among the central
1.3 kb region sequences amplified from the mites (Figure 5), this
could be a consequence of limited experimental sampling and the
higher levels of VDV-1 CP in the population, a conclusion
supported by analysis of the negative strands present (Figure S6).
Although further studies will be required to determine whether
sampling stochasticity accounts for the apparent absence of non-
recombinant DWV in Varroa, together these results suggest that –
at least at the level of the entire mite – there is no selection, either
by absolute presence or replication capability, for the DWVV RF
that accumulates to high levels after mite exposure in VH group
pupae.
Since the diversity of virus present in Varroa indicates that the
near-clonal virus population in the VH group is not due to the
mite delivering either a restricted virus type or to elevated levels of
DWVV in the mite we went on to inoculate pupae with a mixed
virus population prepared from group C pupae and characterised
the resulting virus population after three days. Recipient purple-
eye stage pupae contained high virus loads which, compared with
the inocula, had markedly reduced levels of DWV-like virus and
elevated levels of a VDV-1/DWV recombinant (Figure 6).
Although, the resulting virus diversity was not as limited as seen
in the naturally infected VH group, we attribye this to the
restricted incubation time between inoculation and sampling (3
days vs. 6 days), in part imposed by experimental limitations of
working with late-stage larvae and early-stage pupae which are
vulnerable to handling damage. Despite these limitations, these
results clearly demonstrate that direct inoculation of a mixed virus
preparation, recapitulating virus inoculation by the mite, results in
a marked reduction in virus diversity. We additionally demon-
strated, by RNA-seq analysis of temporally and geographically
independent symptomatic nurse bees and similarly independent
pupae directly injected with virus preparations, that essentially the
same near-clonal virus (DWVV) was present as previously
identified in the VH group pupae. In parallel, control asymptom-
atic nurse bees or mock-injected pupae exhibited high diversity
and low levels of virus (Figure 7, Figure S7, Table S7), as
previously seen in the C and NV groups during the frame transfer
study. The unselective RNA-seq methodology excludes the
possibility that virus clonality at high virus loads was a
consequence of PCR bias. The remarkable restriction in virus
diversity in both injected pupae or symptomatic nurse bees
exhibiting high viral loads was in good agreement with that seen in
group VH pupae (Figure 5) determined following qRT-PCR
amplification (0.15% diversity).
We propose that the strikingly elevated levels and associated
restricted diversity of DWVV (RF4-type; Figure 5) in both the
Varroa-exposed VH group pupae and characteristically DWV
symptomatic nurse bees is because this virus has a preferential
advantage when delivered directly to haemolymph of developing
pupae. There remains the possibility that DWVV alone replicates
to elevated levels in the salivary glands of Varroa and is the only
DWV-like virus transmitted during feeding. However, we do not
favour this hypothesis as we would expect it to result in DWVV
being the predominant virus detected when whole-mite RNA
samples were analysed. Furthermore, we also present evidence
(Figure 7A, Table S7) that DWVV predominates when a mixed
virus population is directly inoculated. Nevertheless, it remains an
intriguing avenue for further study. Assuming this is not the
explanation, the molecular mechanisms underpinning the advan-
tage of the near-clonal DWVV, be it evasion of the host antiviral
response, specific tissue tropism or some other aspect of the virus-
host interaction, will require further studies. This will necessitate
immunohistological analysis of orally infected or injected pupae,
the development of a reverse genetic system to identify determi-
nants of DWV tropism, and the analysis of the contribution of
immune-related (and other) host genes using RNAi-based strate-
gies [72,73].
Conclusions
Without proper management Varroa has a devastating effect on
honeybee colony viability and consequent honey production and
pollination services. We show here that the markedly elevated
levels of DWV-like viruses in Varroa-exposed honeybee pupae are
likely attributable to the direct inoculation of a specific virus,
DWVV, by Varroa to haemolymph. Repeated cycles of Varroa-
replication within an infested colony would preferentially amplify
DWVV, potentially resulting in it becoming the predominant virus
present, transferred both by Varroa and per os. Further studies will
be required to determine whether such a virus, if sufficient were
ingested, would also cause symptomatic infection. Oral suscepti-
bility to a virulent form of DWV may also explain reported cases
of deformed wing disease symptoms seen in Varroa-free colonies in
Hawaii [20] and Scotland (Andrew Abrahams, pers. comm.), but
may also reflect genetic variation and the presence of particularly
susceptible pupae in the colony.
Our study demonstrates that a proportion of Varroa-exposed
pupae (the VL group) do not exhibit elevated levels of the near-
clonal DWVV recombinant (Figure 5). Further in vitro studies will
be required to determine whether these are naturally resistant –
and therefore form the basis for genome wide association studies of
the genetic determinants of virus resistance – or if they reflect the
stochastic nature of the transmission event from the mite.
Materials and Methods
Honeybees, frame transfer experiment and sampling
This study was based around an experiment in which a brood
frame containing newly hatched larvae from a Varroa-free colony
was introduced into a Varroa-infested colony. The larvae were left
to develop within the Varroa-infested colony, and pupae were
collected 11 days later from capped brood cells at the purple eye
stage and analysed using a range of molecular methods. The
Varroa-free honeybee (Apis mellifera) colony with a naturally-mated
one-year-old queen was imported from Colonsay, Scotland, an
island with no historic reports of Varroa incidence and no imports
of honeybees from Varroa-infested areas. This allowed us to
exclude the presence of DWV strains associated with Varroa mite
infestation. As a source of Varroa mites and the mite-associated
DWV strains, we selected a Warwickshire honeybee colony,
heavily infested with Varroa and having high DWV levels in
honeybees and mites. The Varroa-free and Varroa-infested colonies
were contained in separate mesh flight cages (dimensions: 6 meters
long, 2.5 meters wide, 2 meters high) and maintained on an
artificial diet of sugar syrup and pollen. The pollen was imported
from Varroa-free Australia to exclude possible contamination with
Varroa-associated viruses through foraged food and was pre-
screened by PCR before use for DWV-like viruses. In order to
minimise possible effects on honeybee gene expression due to
the differences in nutrition, both the control Varroa-free and the
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Varroa-infested colonies were maintained in flight cages in the same
apiary (at the University of Warwick, UK) and were fed on the
artificial diet for two months before the start of the frame transfer
experiments. Neither colony was treated with miticides.
The experimental infestation, summarised in Figure 1, was
conducted on 4th–15th August 2011. As stated previously, it
involved the transfer of a brood frame, which contained newly
hatched honeybee worker larvae (on day 4 of development), from
the Varroa-free to the Varroa-infested colony. As a result, the
transferred larvae were exposed to Varroa-selected DWV-like
viruses in brood food delivered by the nurse honeybees of the
Varroa-infested colony for five days before brood cell capping on
day nine of development (Figure 1, Treatment 1, Oral DWV
infection). Honeybee larvae were left to develop in the capped cells
for six days and then were sampled as pupae on day 15, when they
had reached the purple-eye stage of development [74]. A
proportion of these brood cells were naturally infested with Varroa
and hence contained pupae that were subjected to mite feeding
(Figure 1, Treatment 2, Mite feeding). We sampled Varroa-infested
pupae and the mites associated with individual pupae, with mite
feeding confirmed by the presence of the mother mite and at least
one protonymph [27]. Control pupae at the same developmental
stage were sampled from the Varroa-free hive at the same time. A
colony from a separate apiary in Warwickshire that exhibited
Varroa mite infestation for over a year was sampled in August 2013
to assess the virus populations in colonies with established Varroa
infestation.
The pupae and the Varroa mites associated with each infested
pupa were individually snap frozen in liquid nitrogen immediately
after being removed from brood cells and stored at 280uC prior to
total RNA extraction. For total RNA extraction, whole individual
honeybee pupae were ground to fine powder in liquid nitrogen,
and half of the powder used for RNA extraction, carried out using
1 mL of Trizol Reagent (Invitrogen) according to the manufac-
turer’s instructions. Total RNA extraction from Varroa mites was
carried out using RNeasy spin columns (Qiagen RNeasy Plant
Mini kit).
Virus purification from honeybee material and extraction of the
viral genomic RNA from virus particles were carried out as
described previously [15].
Microarray transcriptional profiling and statistical analysis
For genome-wide analysis of the honeybee transcriptome total
RNA preparations from eight individual honeybees from each of
the four experimental groups (32 honeybees in total) were purified
further using RNeasy Plant Mini kit spin columns (Qiagen). RNA
concentration, purity and integrity were assessed using a 2100
Bioanalyzer and an RNA 6000 LabChip (Agilent Technologies).
The probe preparation, hybridization and scanning were carried
out according to the Agilent instructions, essentially as in [75].
Total RNA extracts from an individual honeybee were used to
produce Cy3- and Cy5-labelled aRNA samples using a Low Input
RNA fluorescent linear amplification kit (Agilent Technologies),
according to the manufacturer’s instructions. The Cy3-and Cy5-
labelled samples were used in a two-colour dye-balanced loop
design [30,31] for a genome-wide analysis of the honeybee
transcriptome with the custom expression oligonucleotide micro-
array. Four slides, each with eight two-channel arrays were
employed, allowing two replicates per sample, one green and one
red. Different treatment groups were allocated to the green and
red channels in each array; the loop design ensured that each
sample was indirectly compared with all other samples. The array,
in 60K 68 format, included 60 nt oligonucleotides specific to
10,157 transcripts of the Apis mellifera Official Gene Set 1, OGS1
[32]; the array also contained probes to all the honeybee RNA
viruses known to date. Each probe was replicated five times to
enable robust statistical analysis. Sequences of the probes of the
honeybee whole genome expression microarray, a 60-mer
oligonucleotidide array based on the Apis mellifera transcriptome
(OGS1) and Apis mellifera fungal and viral pathogens (Agilent ID:
027104, SurePrint G3 Custom GE 8660K), are available in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress) under ac-
cession number A-MEXP-2251. Following hybridisation, the
microarrays were scanned using Agilent Technologies G2565CA
Scanner and the fluorescence intensity data were processed using
feature extraction software (Agilent Technologies). Cy3 and Cy5
fluorescence intensities for each spot were measured as values of
green and red pixels respectively. The details of the array
experiment design, sample description, and microarray data are
available in the ArrayExpress database (www.ebi.ac.uk/
arrayexpress) [76] under accession number E-MTAB-1285. One
array failed (assigned to VL green and NV red) leaving 62
channels for final analysis.
For additional confirmation we conducted qRT-PCR analysis
with primers specific to Paenibacillus larvae ssp and Melissococcus
plutonius (Table S1), the causal agents of American foulbrood and
European foulbrood, respectively, which showed that the samples
were free of detectable levels of these bacterial pathogens.
The unprocessed intensity scanning values were both within-
array and between-array normalized using the linear model based
Limma R package [77]. Differentially expressed (DE) genes in all
six possible contrasts were found using Limma (via function
‘‘lmscFit’’ incorporating intraspot correlation) and also the R
GaGa package for gamma-gamma Bayesian hierarchical modeling
[78–80]. A gene was considered as differentially expressed (DE) in
a given contrast (using a t-statistic moderated across genes) when
the average expression exceeded 6.0, the fold change exceeded
14%, the Limma analysis p-value adjusted for multiple genes was
less than 0.05 and the posterior probability determined by GaGa
was above 0.6. Microarray results were validated by qRT-PCR
using a set of primers for certain honeybee genes and DWV (Table
S1).
For Gene Ontology (GO) analysis a three-stage process was
used. Genes in the latest A. mellifera genome annotation, Amel_4.0
(http://hymenopteragenome.org/beebase), corresponding to
genes in A. mellifera OGS1 were found using protein blast. GO
terms associated with Amel_4.0 genes were then obtained using
Blast2GO [81] with the SwissProt database option. Finally, over-
and under-represented GO terms in the sets of DE honeybee
OGS1 genes in each contrast were obtained with BiNGO, using a
hypergeometric test, a Benjamini and Hochberg FDR correction
and a significance level of 0.05 [82].
For Principal Component Analysis (PCA), the significant DE
genes in all six contrasts were pooled and ranked by their adjusted
p-value. The 60 with the lowest adjusted p-value were selected, all
of which appeared in the contrast C to VH; the other contrasts’
contributions were 35 (C to VL), 21 (NV to VH), 19 (C to NV), 4
(NV to VL) and 11 (VL to VH) genes. Principal components of the
expression profiles across the 62 microarray channels were found
and (the first two) plotted using the princomp and biplot functions
in R [83].
Next generation sequencing of small RNA libraries
For high throughput sequencing of small RNA, we pooled equal
amounts of the Trizol-extracted total RNA from individual
honeybees and isolated the 15 to 40 nt RNA fraction, which was
separated using denaturing polyacrylamide gel. The RNA pools
were ligated to the oligonucleotide adapters, reverse-transcribed
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and amplified using the TruSeq Small RNA Sample Prep Kit
(Illumina small RNA kit). The libraries were sequenced using the
Illumina HighSeq 2000 platform, producing 15–25 million reads
per libraries (GATC-Biotech, Germany). The small RNA NGS
sequencing data are available in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) [76] under accession number E-MTAB-
1671. The reads were cropped to remove adapter sequences and
aligned to reference viral and miRNA sequences using Bowtie
[37]. Samtools mpileup was used to produce the siRNA and
miRNA coverage profiles.
Characterization of viral RNA
Real-time reverse transcription PCR was carried out essentially
as in [15]. In brief, RNA extracts were treated with DNAse, then
purified DNA-free total RNA preparations were used as a
template to produce cDNA using random primer and Superscript
III reverse transcriptase (Invitrogen). The cDNA samples pro-
duced were used for real-time PCR quantification of the DWV or
host transcripts using SYBR green mix (Agilent Technologies).
Oligonucleotide primers are summarized in Table S1.
For strand-specific quantification of viral RNA of DWV and
VDV-1 types reverse transcription was carried out at 50uC using
Superscript III reverse transcriptase (Invitrogen) and the tagged
primers designed to anneal to the negative strands RNA of DWV
or VDV-1, primers 389 and 391 respectively (Table S1). The
qPCR step was carried out using corresponding DWV or VDV-1
specific primers in negative polarity (Table S1, Primers 1384 or
1382) and primer 388 identical to the sequence of the tag (Table
S1, primer 388).
Amplification of the cDNA fragments corresponding to the
central region of DWV genomic RNA was carried out by nested
PCR using GoTaq PCR mix (Promega) and primers 155 and 156
(Table S1) using the cDNA extracted from the honeybees and the
mites, pooled according to their treatment groups. The outside
PCR primers were designed to amplify all known DWV-like
sequences. For each first round reaction we carried four second
round amplification reactions using VDV-1- or DWV-specific
primers, 151–154 (Table S1), which allowed distinction of VDV-1-
type and DWV-type CP and NS regions, thereby enabling
amplification of all potential combinations, even those present at
very low levels. The PCR fragments were cloned into pGemT-
Easy (Promega) and sequenced using the Sanger dideoxy method.
GenBank accession numbers for the reported sequences are
JX661628–JX661712 and KC249926–KC249933. The full-
length cDNA of DWV, GenBank accession number KJ437447,
was amplified by RT-PCR using primers specific to the published
termini of DWV and VDV-1 RNA and cloned into the pCR-
TOPO-XL vector (Invitrogen) as described in [15]. The
sequences were aligned using CLUSTAL X [84], and
phylogenetic analysis of the sequences was carried out using
the PHYLIP package [85].
For the next generation sequencing of RNA, a series of
overlapping cDNA fragments were produced using viral RNA or
total RNA preparations using the set of primers designed to the
sequences of the genomic RNA conserved among DWV, VDV-1
and KV (Table S1). The fragments were pooled and libraries of
paired-end reads (101 nt.), about 5 million per sample, were
generated using an Illumina HiSeq 2000 (GATC-Biotech). The
virus genomic RNA NGS sequencing data are available in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress) [76] under
accession number E-MTAB-1675.
The next generation sequencing of the poly(A) RNA
fraction (RNA-seq) of the total RNA preparations isolated
from the honeybees was carried out using Illumina HiSeq 2000
(GATC-Biotech) protocol, with about 10 million 101 nucleotide-
long reads generated for each sample. The RNA-seq sequencing
data are available in the EBI Sequence Read Archive [86] under
accession number PRJEB5249. This RNA-seq dataset was used to
calculate Shannon’s diversity index values of DWV populations
using the following procedure. First we selected the reads aligning
to the reference DWV and VDV-1 sequences (GenBank Accession
numbers GU109335 and AY251269 respectively) from the
original RNA-seq libraries using Bowtie. To take into account
the effect of difference in coverage of low virus levels and high
virus level RNA-seq libraries we used two approaches, (i)
correction for NGS error for complete libraries (Text S1 and
Wood et al., unpublished data) and (ii) multiple sampling. For the
latter we produced five samples of 3285 reads (the lowest number
of the viral reads among the libraries), which were aligned using
Bowtie to the reference DWV and VDV-1 sequences, and the
NGS nucleotide pileups were then generated for each nucleotide
position of the reference sequences using samtools. Shannon’s
diversity index of the aligned nucleotides was calculated for each
position in the reference sequence. Then, the average Shannon’s
index values were calculated for the selected regions in the
reference genomes for each sample. The averages values of and
standard deviation of five samples were used in the statistical
analysis.
Supporting Information
Figure S1 Bimodal distribution of DWV accumulation
in the experimental honeybee pupae. (A) Dotplot of Ct
values by experimental group, determined by qRT-PCR, showing
means and 95% confidence intervals for the means. The means for
C, NV and VL are not significantly different. The difference
between the mean of VH and the pooled C, NV and VL is
significant with p-value ,10216. (B) A histogram shows bimodality
of Ct values.
(PDF)
Figure S2 Orthogonality of the differential gene expres-
sion pattern. A geometrical visualization of the three-stage
experimental process. The first stage is ‘‘frame transfer’’ which
includes exposure to Varroa-selected viruses through feeding at
larval stage (contrast C to NV), the second stage is exposure to the
Varroa mite feeding on the pupae haemolyph (contrast NV to VL)
and the third stage is development of high viral load (contrast VL
to VH). (A) Numbers of significantly differentially expressed genes
in each of the three stages are shown alongside the directional
vectors, together with numbers of differentially expressed genes in
the composite stages (contrasts C to VL, NV to VH, C to VH). (B)
The three stages involve distinct sets of differentially expressed
genes, depicted in the graphic as orthogonality of the associated
vectors; the very small number of genes common to pairs of
contrasts are shown. (C) The large number of differentially
expressed genes common to the pairs of non-orthogonal contrasts
are shown.
(PDF)
Figure S3 Principal component analysis (PCA) pro-
duced with 30 genes selected from the top genes from
each contrast ranked by adjusted p-value. The genes were
selected as follows: 7 top genes were selected from each of the 6
contrasts, and the 30 with the lowest adjusted p-values used in
subsequent analysis. The scatterplot of the first two principal
components for all honeybee samples (average for Cy3 and Cy5
replicates) is shown.
(PDF)
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Figure S4 Summary of numbers of differentially ex-
pressed immune-related genes. The number of up- and
down-regulated genes in each contrast are marked, respectively, as
q andQ. An up-regulated gene level is higher at the head arrow
showing the contrast; commonality is shown in brackets.
(PDF)
Figure S5 Correlation between the virus levels in
honeybee pupae and the corresponding mites. Two-
dimensional plots showing the results of the qRT-PCR quantifi-
cation of viral RNA in the honeybee pupae (log10 transformed
copy number of the viral RNA per honeybee) and the
corresponding Varroa mites (log10 transformed viral RNA copy
number normalised to Varroa b-actin copy number) from
experiment groups VL and VH. Panels shows results of (A) total
DWV-like virus quantified with the primers recognising the NS
region of DWV, VDV-1 and KV, then specific quantification of
(B) VDV-1 CP, (C) VDV-1 NS, (D) DWV CP and (E) DWV NS
regions.
(PDF)
Figure S6 Quantification of negative strands of DWV
RNA in the Varroa mites of the groups VH and VL. The
graph shows average copy number per mite of DWV- and VDV-
1-like CP-coding sequence as determined by negative-strand
specific qRT-PCR using primers listed in Table S1. The dotted
line indicates the detection threshold as determined by a water-
only control plus two standard deviations.
(PDF)
Figure S7 Genetic diversity of DWV in the honeybee
groups. Average Shannon’s diversity index values. (A) the CP
region positions 1751 to 4595, (B) the NS region, positions 5008 to
9826, and the central region, positions 5250 to 6250. Positions are
given for the reference DWV genome, GenBank Accession
number AJ489744. Average Shannon’s index was calculated for
five random 3285-read samples from the viral reads for each NGS
library of individual bees. Bars indicate SD. Letters above the bars
represent statistically significant groupings according to Fisher’s
Least Significant Difference (LSD) test as 5% and 0.1% levels,
marked with * and *** respectively. The dashed lines indicate the
average Shannon’s diversity index values for the NGS sequencing
error, 6 standard deviation (SD). In panel (C) the dotted line at
0.0417 marks the Shannon’s diversity index for Group NV of the
frame transfer experiment.
(PDF)
Table S1 Oligonucleotides used in this study. Primer
descriptions are given as follows: target (position in DWV or
VDV-1 nucleotide sequence), polarity (F, forward; R, reverse).
GenBank accession numbers used to express primer positions are
AJ489744 (DWV), NC_006494 (VDV-1), and AB242568 (Varroa
destructor b-actin mRNA).
(PDF)
Table S2 Honeybee genes differentially expressed in
the experiment. Shown are, the honeybee OGS1 gene ID,
adjusted P-value, average expression levels in the groups (C, NV,
VL, VH), and the contrasts where the given gene is differentially
expressed (NV-C (1), VL-C (2), VH-C (3), VL-NV (4), VH-NV (5),
VH-VL (6)).
(PDF)
Table S3 Summary of gene expression commonality
between the contrasts. Number of differentially expressed
genes common to pairs of contrasts. In each cell (corresponding to
the pair of contrasts) the three figures show the commonality for all
differentially expressed genes in the pair, the up-regulated genes in
the pair, and the down-regulated genes in the pair respectively.
(PDF)
Table S4 Significantly overrepresented GO terms (Bio-
logical Process, BP, terms) in the contrasts (corrected p-
value ,0.05).
(PDF)
Table S5 Summary of the small RNA sequencing in the
experimental groups. The single read libraries were aligned
using Bowtie [37] to Apis mellifera miRNA [36], and to the
reference full-length DWV and VDV-1 sequences, GenBank
Accession numbers GU109335 and AY251269 respectively.
(PDF)
Table S6 Correlation of virus-specific siRNA coverage
between experimental groups. Pearson correlations, P,
0.001 are shown. The small RNA libraries determined by high-
throughput sequencing were aligned to the DWV or VDV-1
sequences (GenBank Accession numbers GU109335 and
AY251269 respectively) using bowtie [37]. All reads VDV-1 or
DWV pileup values numbers of the DWV- and VDV-1- specific
small RNA reads, up to 3 mismatches were allowed for the 18 nt
seed region.
(PDF)
Table S7 Summary of the NGS libraries and consensus
viral sequences from individual honeybees from Varroa-
infested colony. RNA-seq libraries were produced using poly(A)
RNA extracts. The reads were aligned to the reference full-length
DWV and VDV-1 sequences, GenBank Accession numbers
GU109335 and AY251269 respectively, using the ‘‘ —very-
sensitive-local’’ option which allowed the highest number of
mismatches. The aligned reads were used to generate consensus
nucleotide sequences. The assembled viral sequences showed
highest identity with the DWV-VDV-1 recombinant clone
identified in the sampled colony (GenBank Accession number
KJ437447) and the group VH sequences (e.g. GenBank Accession
number JX661656).
(PDF)
Table S8 Differential expression of putative homeobox
genes in the contrasts.
(PDF)
Text S1 Next generation sequencing: error correction
and diversity testing outline.
(PDF)
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